521 related articles for article (PubMed ID: 35163820)
1. Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke.
Nilles KL; Williams EI; Betterton RD; Davis TP; Ronaldson PT
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163820
[TBL] [Abstract][Full Text] [Related]
2. Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats.
Stanton JA; Williams EI; Betterton RD; Davis TP; Ronaldson PT
Exp Neurol; 2022 Nov; 357():114181. PubMed ID: 35905840
[TBL] [Abstract][Full Text] [Related]
3. Transporter-Mediated Delivery of Small Molecule Drugs to the Brain: A Critical Mechanism That Can Advance Therapeutic Development for Ischemic Stroke.
Williams EI; Betterton RD; Davis TP; Ronaldson PT
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32075088
[TBL] [Abstract][Full Text] [Related]
4. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
Abdullahi W; Davis TP; Ronaldson PT
AAPS J; 2017 Jul; 19(4):931-939. PubMed ID: 28447295
[TBL] [Abstract][Full Text] [Related]
5. Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs.
Ronaldson PT; Davis TP
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890396
[TBL] [Abstract][Full Text] [Related]
6. Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke.
Brzica H; Abdullahi W; Ibbotson K; Ronaldson PT
J Cent Nerv Syst Dis; 2017; 9():1179573517693802. PubMed ID: 28469523
[TBL] [Abstract][Full Text] [Related]
7. Oatp (Organic Anion Transporting Polypeptide)-Mediated Transport: A Mechanism for Atorvastatin Neuroprotection in Stroke.
Williams EI; Betterton RD; Stanton JA; Moreno-Rodriguez VM; Lochhead JJ; Davis TP; Ronaldson PT
Stroke; 2023 Nov; 54(11):2875-2885. PubMed ID: 37750296
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-
Betterton RD; Abdullahi W; Williams EI; Lochhead JJ; Brzica H; Stanton J; Reddell E; Ogbonnaya C; Davis TP; Ronaldson PT
Drug Metab Dispos; 2022 Jul; 50(7):942-956. PubMed ID: 35504656
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery.
Thompson BJ; Sanchez-Covarrubias L; Slosky LM; Zhang Y; Laracuente ML; Ronaldson PT
J Cereb Blood Flow Metab; 2014 Apr; 34(4):699-707. PubMed ID: 24473481
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
11. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
12. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.
Roth M; Obaidat A; Hagenbuch B
Br J Pharmacol; 2012 Mar; 165(5):1260-87. PubMed ID: 22013971
[TBL] [Abstract][Full Text] [Related]
13. CNS Drug Delivery in Stroke: Improving Therapeutic Translation From the Bench to the Bedside.
Ronaldson PT; Williams EI; Betterton RD; Stanton JA; Nilles KL; Davis TP
Stroke; 2024 Jan; 55(1):190-202. PubMed ID: 38134249
[TBL] [Abstract][Full Text] [Related]
14. Species differences in drug transporters and implications for translating preclinical findings to humans.
Chu X; Bleasby K; Evers R
Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):237-52. PubMed ID: 23256482
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of organic cation and anion transporters (SLC22 family) in the CNS.
Farthing CA; Sweet DH
Curr Pharm Des; 2014; 20(10):1472-86. PubMed ID: 23789957
[TBL] [Abstract][Full Text] [Related]
16. In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions.
Kindla J; Fromm MF; König J
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):489-500. PubMed ID: 19416085
[TBL] [Abstract][Full Text] [Related]
17. Functional Expression of Organic Ion Transporters in Astrocytes and Their Potential as a Drug Target in the Treatment of Central Nervous System Diseases.
Furihata T; Anzai N
Biol Pharm Bull; 2017; 40(8):1153-1160. PubMed ID: 28768996
[TBL] [Abstract][Full Text] [Related]
18. Sex-specific differences in organic anion transporting polypeptide 1a4 (Oatp1a4) functional expression at the blood-brain barrier in Sprague-Dawley rats.
Brzica H; Abdullahi W; Reilly BG; Ronaldson PT
Fluids Barriers CNS; 2018 Sep; 15(1):25. PubMed ID: 30208928
[TBL] [Abstract][Full Text] [Related]
19. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effects of eighteen front-line antibiotics on the substrate uptake mediated by human Organic anion/cation transporters, Organic anion transporting polypeptides and Oligopeptide transporters in in vitro models.
Lu X; Chan T; Zhu L; Bao X; Velkov T; Zhou QT; Li J; Chan HK; Zhou F
Eur J Pharm Sci; 2018 Mar; 115():132-143. PubMed ID: 29307856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
